Holdings of Health Sciences Portfolio
PACIFIC SELECT FUND ·133 declared positions · as of Mar 31, 2026
Original filing · Net assets 356.8M $ · Ten largest lines: 50.4 % of the equity sleeve
Sector breakdown
- Health care 81.2 %
- Materials 0.6 %
- Technology 0.3 %
- Consumer discretionary 0.3 %
- Industrials 0.2 %
- Unattributed 17.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.5 %
- GBP 1.3 %
- CHF 0.6 %
- EUR 0.3 %
- JPY 0.2 %
- DKK 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 93.5 %
- IL 1.8 %
- NL 1.5 %
- GB 1.3 %
- CH 0.7 %
- BE 0.3 %
- BM 0.2 %
- JP 0.2 %
- CA 0.1 %
- JE 0.1 %
- DK 0.1 %
- DE 0.1 %
- Other countries 0.1 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 116 | 325.7M $ | 93.46 % |
| IL | 1 | 6.2M $ | 1.79 % |
| NL | 1 | 5.4M $ | 1.54 % |
| GB | 2 | 4.5M $ | 1.29 % |
| CH | 2 | 2.5M $ | 0.72 % |
| BE | 2 | 1M $ | 0.29 % |
| BM | 1 | 787.8K $ | 0.23 % |
| JP | 1 | 749.6K $ | 0.22 % |
| CA | 1 | 413.2K $ | 0.12 % |
| JE | 1 | 374.9K $ | 0.11 % |
| DK | 1 | 230.5K $ | 0.07 % |
| DE | 1 | 226.1K $ | 0.06 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Maze Therapeutics Inc | 10,886 | 324.9K $ | 0.09 % |
| Monte Rosa Therapeutics Inc | 18,858 | 310.2K $ | 0.09 % |
| Vaxcyte Inc | 5,243 | 304.7K $ | 0.09 % |
| Dyne Therapeutics Inc | 16,708 | 302.9K $ | 0.08 % |
| Alcon AG | 3,978 | 299.7K $ | 0.08 % |
| Aktis Oncology Inc | 16,038 | 286.9K $ | 0.08 % |
| Denali Therapeutics Inc | 14,927 | 286.6K $ | 0.08 % |
| Kymera Therapeutics Inc | 3,245 | 270.3K $ | 0.08 % |
| KalVista Pharmaceuticals Inc | 12,713 | 255.9K $ | 0.07 % |
| CG oncology Inc | 3,612 | 244.5K $ | 0.07 % |
| Beam Therapeutics Inc | 10,063 | 239.8K $ | 0.07 % |
| Zealand Pharma A/S | 4,949 | 230.5K $ | 0.06 % |
| BioNTech SE | 2,544 | 226.1K $ | 0.06 % |
| PTC Therapeutics Inc | 2,902 | 197.7K $ | 0.06 % |
| Bicara Therapeutics Inc | 9,489 | 188.7K $ | 0.05 % |
| Upstream Bio Inc | 20,337 | 183K $ | 0.05 % |
| Allogene Therapeutics Inc | 73,377 | 179K $ | 0.05 % |
| Biohaven Ltd | 20,827 | 176.2K $ | 0.05 % |
| WaVe Life Sciences Ltd | 20,393 | 147.8K $ | 0.04 % |
| EyePoint Inc | 11,146 | 143.7K $ | 0.04 % |
| Ocular Therapeutix Inc | 15,472 | 131K $ | 0.04 % |
| Vor BioPharma Inc | 6,863 | 122.4K $ | 0.03 % |
| REGENXBIO Inc | 12,859 | 107.8K $ | 0.03 % |
| Corvus Pharmaceuticals Inc | 6,673 | 97.6K $ | 0.03 % |
| Voyager Therapeutics Inc | 22,232 | 85.8K $ | 0.02 % |
| Syndax Pharmaceuticals Inc | 3,465 | 80.9K $ | 0.02 % |
| MoonLake Immunotherapeutics | 3,966 | 73.9K $ | 0.02 % |
| 4D Molecular Therapeutics Inc | 7,665 | 71.4K $ | 0.02 % |
| Nyxoah SA | 20,566 | 60.1K $ | 0.02 % |
| Orchestra BioMed Holdings Inc | 12,512 | 53.2K $ | 0.01 % |
| TScan Therapeutics Inc | 33,788 | 34.1K $ | 0.01 % |
| Autolus Therapeutics PLC | 16,672 | 23K $ | 0.01 % |
| Gossamer Bio Inc | 21,834 | 7.2K $ | 0.00 % |